Trophoblastic Tumor Placental SiteSymptoms, Doctors, Treatments, Advances & More
Learn About Trophoblastic Tumor Placental Site
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Olson Center For Women's Health At Durham Outpatient Center
Sarosh Rana is a Neonatologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 31 years. Dr. Rana is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Preeclampsia, High Blood Pressure in Infants, Peripartum Cardiomyopathy, and Neuralgia.
Tower Health Medical Group Gynecologic Oncology - West Reading
. Dr. Robinson is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Cervical Cancer, and Bladder Reconstruction. Dr. Robinson is board certified in American Board Of Obstetrics And Gynecology.
Yale University
Eric Winer is an Oncologist and a Hematologist Oncology provider practicing medicine in New Haven, Connecticut. Dr. Winer is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Breast Cancer in Men.
Summary: The purpose of this study is to establish a prospective, single-center platform research based on clinical subtypes to explore precision neoadjuvant therapy in patients with operable breast cancer who met the indications for neoadjuvant chemotherapy and by the update of basic translational research in the center, especially the refinement of typing, the discovery of new targets and the development...